Dr. Phulrenu has completed her DM (Endocrinology), M.D. (General Medicine), M.B.B.S from Seth G. S. Medical College & K.E.M. Hospital.
• Guide and Post Graduate teacher for DNB Endocrinology students since 28 years at P. D. Hinduja Hospital & Medical Research Centre.
• Head, T1DI Project, a non-profit project for Type 1 diabetic kids at P. D. Hinduja Hospital funded by Hinduja Foundation
• Member MUHS Board of studies committee [ Medicine and Allied- Superspeciality
• Member – Maharashtra University of Health Sciences (MUHS) Board of Studies Committee for Medicine and Allied- Superspeciality courses.
• Teacher for Diploma Diabetology candidates under College of Physicians & Surgeons at Hinduja Healthcare Surgical, Khar, Mumbai.
• Teacher for Diabetes Diploma Students at Bombay University for 5 years.
• 35 years of experience as a Postgraduate Teacher for General Medicine at Seth G.S. Medical College & KEM Hospital, Mumbai.
• Co-guide to student doing Post Graduate Diploma Course in Clinical Nutrition and Dietetics of SVT College of Home Science, SNDT Women's University, Juhu.
• Teacher for Fellowship in Diabetology at P.D. Hinduja National Hospital & Medical Research Centre, Mahim, Mumbai.
• Resource Person for ongoing Nursing Education programmes at P.D. Hinduja National Hospital & Medical Research Centre
Type 1 Diabetes Mellitus,
Thyroid Disorders, including Thyroid Cancer, Thyroid Nodules & Goitre,
Polycystic Ovary Syndrome (PCOS) / Polycystic Ovarian Disease (PCOD),
Hirsutism & Acne Related to Hormonal Disorders,
Parathyroid & Calcium Disorders,
Vitamin D Deficiency,
Perimenopausal Hormonal Management,
Pituitary Disorders,
Metabolic Bone Diseases & Osteoporosis,
Obesity & Clinical Nutrition,
Hormonal & Endocrine Disorders
Executive Management Program in Healthcare - University of Virginia
Diploma in Comparative Mythology from Kalina University, Mumbai
• Association of Physician of India
• Endocrine Society of India
• Maha Endocrine Society
• Endocrine Society (USA)
• Indian Academy of Paediatrics
• Menopause Society of India
• Indian Society for Paediatric and Adolescent Endocrinology
• Indian Society of Bone Metabolism and Research
- Association of Physician of India
- Endocrine Society of India
- Maha Endocrine Society
- Endocrine Society (USA)
- Indian Academy of Paediatrics
- Menopause Society of India
- Indian Society for Paediatric and Adolescent Endocrinology
- Indian Society of Bone Metabolism and Research
1. Spontaneous Resolution of a Pituitary Mass: Probable Lymphocytic Hypophysitis
Authors'. Nalini Shah, Dr. Padma S. Menon, Dr. P.H. Chauhan, Dr. R.D. Nagpal, Dr. A.P. Desai
Journal: JAPI
2. Post Partum Thyroiditis
Author: Dr. P.H. Chauhan
Journal: Endocrine Newsletter, Vol. 5, No. 3, 1996
3. Infections Associated with Diabetes Mellitus
Authors: Dr. P.S. Menon, Dr. P.H. Chauhan
Year: 1999
4. Lymphocytic Hypophysitis
Author: Dr. P.H. Chauhan
Journal: Endocrine Newsletter, Vol. 9, No. 4, 1999
5. Prevention of Osteoporosis
Author: Dr. P.H. Chauhan
Journal: Journal of General Medicine, Vol. 22, July 2010
6. Study of Primary Hyperparathyroidism: Tertiary Hospital Experience
Journal: Indian Journal of Endocrinology and Metabolism (ESICON Supplement)
Year: December 2012
7. Thyroid Disorders in Women
Journal: Journal of Association of Medical Women of India
Year: September 2012
8. Cystic Parathyroid Adenoma: An Experience of Four Patients
Journal: Journal of ASEAN Federation of Endocrine Societies
Year: November 2012
9. Management of Polycystic Ovarian Disease (PCOD)
Journal: Indian Journal of Dermatology
Year: 2013
10. Thyroid Disorders in Pregnancy (Book Chapter)
Book: Manual of Reproductive Endocrinology (MOGS)
Year: January 2013
11. Accuracy and Comparison of Different Glucometers
Journal: Indian Journal of Endocrinology and Metabolism, Supplement 3, Vol. 17
Year: December 2013
12. Thyroid Haemorrhage Post FNAC
Journal: JAPI
Year:2015
13. Fracture Liaison Service: Prevention by Co-ordination
Journal: Indian Journal of Endocrinology and Metabolism
Citation: 2018;22(7):19–21
14. Endocrinology: The Way Forward
Journal: Indian Journal of Endocrinology and Metabolism
Citation: 2018;22: S1–S2
15. Tumor-Induced Osteomalacia: Experience from Three Tertiary Care Centers in India
Journal: Endocrine Connections
Year: 2019
16. A Study to Assess Clinical Profile of Indian Type 2 Diabetes Mellitus Patients Treated with Teneligliptin – ASPIRE Study
Journal: International Journal of Basic and Clinical Pharmacology
Citation: 2019; 8:1542–1545
17. Long-term Hormonal and Imaging Outcomes of Adjunctive Gamma Knife Radiosurgery in Non-functioning Pituitary Adenomas: A Single Center Experience
Journal: Journal of Neuro-Oncology
Year: 2022
18. 46XX Testicular Disorder of Sex Development
Journal: Journal of Human Reproductive Sciences
Year: 2022
19. Late-Onset Non-Islet Cell Tumor Hypoglycemia Associated with a Pleural Solitary Fibrous Tumor
Journal: Turkish Journal of Endocrinology and Metabolism
Year: 2022
20. Prevalence of Bacterial Urinary Tract Infection Among Patients with Type 2 Diabetes Mellitus on Sodium-Glucose Cotransporter-2 Inhibitors: A Prospective Real-World Setting Study
Journal: Journal of ASEAN Federation of Endocrine Societies
Year: 2022
21. Use of Ultrasound Elastography in Differentiating Benign from Malignant Thyroid Nodules: A Prospective Study
Journal: Journal of Diabetes & Metabolic Disorders
Year: 2023
22. Differences in the Clinical Presentation and Biochemical Profile of Patients with Primary Hyperparathyroidism with Regard to Their Serum Vitamin D Levels: A Single-Center Experience
Journal: Indian Journal of Surgical Oncology
Year: 2023
23. Erectile Dysfunction and Low Serum Testosterone in Indian Diabetic Men: Prevalence and Risk Factors
Journal: Men's Health Journal
Year: 2023
24. Differences in the Presentation and Outcome Between Premenopausal and Postmenopausal Primary Hyperparathyroidism in Indian Women: A Single-Center Experience
Journal: Journal of Mid-life Health
Year: 2023
25. Unmasking of Central Diabetes Insipidus on Initiation of Glucocorticoid Replacement Therapy in a Patient with Panhypopituitarism
Journal: Journal of Clinical and Scientific Research
Year: 2023
Abstracts Published
1.Differences in the Clinical, Laboratory and Operative Variables Between Premenopausal and Postmenopausal Primary Hyperparathyroid Women: A Single-Center Experience
Journal: Endocrine Abstracts
Year: 2023
2. Bilateral Inferior Petrosal Sinus Sampling and Utility of Maximum Stimulated Petrosal Sinus ACTH to Baseline ACTH Ratio in Adrenocorticotropin-dependent Cushing's Syndrome
Journal: Endocrine Abstracts
Year: 2023
3. Single-center Experience with Bilateral Inferior Petrosal Sinus Sampling (BIPSS) in Adrenocorticotropin-dependent Cushing's Syndrome
Journal: Indian Journal of Endocrinology and Metabolism (Supplement)
Year: 2022
4. Prevalence of Auto-antibodies in Children and Adolescents with Type 1 Diabetes and Their Association with Clinical Parameters
Journal: Indian Journal of Endocrinology and Metabolism (Supplement)
Year: 2022
5. Case Series of Wolfram Syndrome – Experience at a Tertiary Care Centre
Journal: Indian Journal of Endocrinology and Metabolism (Supplement)
Year: 2022
6. Effect of Six Months of Combined Estrogen and Progestin Treatment on Anti-Müllerian Hormone in Patients with Polycystic Ovary Syndrome
Journal: Indian Journal of Endocrinology and Metabolism (Supplement)
Year: 2022
7. Insulin Autoimmune Syndrome
Journal: Indian Journal of Endocrinology and Metabolism (Supplement)
Year: 2022
As Principal Investigator:
• A Multicenter, Double-Blind Study to Determine the Efficacy and Safety of SYR-322 plus Pioglitazone HCl, (Actos ®), SYR-322 Alone or Pioglitazone HCl Alone in Subjects with Type 2 Diabetes.
• Open non-comparative, multi-centre study to determine the efficacy and safety of Rimonabant in overweight or obese subjects.
• A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus.- 2017.
• Ongoing- Multicentric T1D1 study at P. D. Hinduja National Hospital and M.R.C., Mumbai.
• Endocrine dysfunction with immune checkpoint inhibitors in cancer patients: A prospective
observational study-ongoing
• Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Prandial Technosphere® Insulin Inhalation Powder Versus Placebo Inhalation Powder in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Oral Antidiabetic Drugs Over a 24-week Treatment Period. – 2020 Compare the sensitivity of high resolution of ultrasonography (USG) of the neck with 99mTc- Sestamibi (MIBI) imaging for detection of parathyroid lesion in primary hyperparathyroidism-completed 2023
As Co-Investigator:
• A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination with Metformin IR or Metformin XR in Pediatric Patients with Type 2 Diabetes who have Inadequate Glycemic Control.- 2006
• Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents with Type 2 Diabetes.- 2009
• Randomized, placebo controlled clinical trial to assess the safety and efficacy of Odanacatib (Mk-0822) to reduce the fracture in osteoporotic postmenopausal women treated with Vitamin D and Calcium.- 2009
• Registry of People with Diabetes in India with Young Age at Onset. - 2012
• Effect of liraglutide or glimepiride added to metformin on blood glucose control in subjects with type 2 diabetes. - 2013
• Control on Metformin Alone. A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to LANTUS® in Adult Patients with Type 2 Diabetes Mellitus: The Element 5 Study. - 2019
• A 24-week Prospective Non-Interventional Post-Marketing Surveillance Study on Adverse Events and Serious Adverse Events in Patients with Type 2 Diabetes Mellitus in India being started on Dulaglutide (Trulicity™)- 2018
• A Randomized, Multicentre, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (≥10 to 18 years) with Type 2 Diabetes Mellitus. - 2018
• Semaglutide outcome trial in cardiovascular events. - 2019
• A registry for secondary fracture prevention service, implemented by healthcare systems for the treatment of Osteoporotic patients. – 2019
Speaker in National and International Conferences
• MAHAENDOCON-2025
• ATTD-ASIA-2025
• INSULIN PUMP WORKSHOP, T1DI FEB-2025
• HOPE CONCLAVE-2026
• Numerous publications in indexed and peer-reviewed national and international journals.
• Chapters in textbooks, clinical books of Diabetes, Reproductive Endocrinology and General Medicine, Metabolism and Endocrinology.
Diabetes